Phase 2 study of Arikace for treatment of pseudomonas lung infections - MPR
Links shared publicly online about this topic.
- 1,665total visits
Phase 2 study of Arikace for treatment of pseudomonas lung infections - MPR
empr.com —
Transave reported additional positive clinical trial results on its lead investigational drug, Arikace (liposomal amikacin for inhalation), an antibiotic to treat chronic lung infections.
View full resource at empr.com
Tags: Infection, Lung, Drug, Phase 2 Clinical Trial, Clinical Trial, Antibiotic, News
Most Recently Shared on October 19, 2009 at 3:40 pm By:
MPR News: Phase 2 study of Arikace for treatment of pseudomonas lung infections: Transave reported addi.. http://bit.ly/Wk3E9
Advertisement
